LMR Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
LMR Partners's IOVA Position: Q3 2026 in Review
LMR Partners held its Iovance Biotherapeutics (IOVA) position steady in Q3 2026 at 41,211 shares worth $611K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.
LMR Partners first reported a position in IOVA in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.8M in Q1 2024. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- LMR Partners held 41,211 shares of Iovance Biotherapeutics worth $611K as of Q3 2026.
- LMR Partners left its Iovance Biotherapeutics share count unchanged in Q3 2026.
- Iovance Biotherapeutics made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1184 holding.
- LMR Partners first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 24 quarters since.
- LMR Partners's Iovance Biotherapeutics position peaked at $1.8M in Q1 2024.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.